Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 1 and Phase 2 Clinical Trials of Cancer Chemoprevention Agents
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
University of Virginia
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Characterizing the Mechanism of DPP8/9 Inhibitor-Induced Pyroptosis
Temporal Patterns of Deep Brain Stimulation
Understanding the Risk of Bat Coronavirus Emergence
The Care Ecosystem: Navigating patients and caregivers through stages of dementia care
Treatment for Homeless
Recently added grants:
Latexin function in the maintenance and regeneration of the hematopoietic system
Cerebrovascular reserve and white matter disease in patients with anemia
Role of KCNQ2 channels in control of breathing
Biology of innate IL-22 during lung fungal infection
Progression of interstitial lung abnormalities: the role of imaging and telomere length regulation
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN35153-9-0-1
Application #
7579653
Study Section
Project Start
2003-09-30
Project End
2008-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemoprevention Agents
/ University of Wisconsin Madison
$1,614,000
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
Bailey, Howard /
$1,058,141
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemoprevention Agents
/
Comments
Be the first to comment on this grant